{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:34:56Z","timestamp":1780104896291,"version":"3.54.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.gastrohep.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T17:21:03Z","timestamp":1554139263000},"page":"316-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelaci\u00f3n intestino-h\u00edgado"],"prefix":"10.1016","volume":"42","author":[{"given":"Paulina","family":"N\u00fa\u00f1ez F.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Quera P.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2019.02.004_bib0410","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0415","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14740\/gr990w","article-title":"Hepatobiliary manifestations and complications in inflammatory bowel disease: A review","volume":"11","author":"Fousekis","year":"2018","journal-title":"Gastroenterol Res."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0420","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2036.2011.04753.x","article-title":"Review article: Colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"34","author":"Torres","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0425","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"Trikudanathan","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0430","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.suc.2015.08.002","article-title":"Extraintestinal manifestations associated with inflammatory bowel disease","volume":"95","author":"Brown","year":"2015","journal-title":"Surg Clin North Am."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0435","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0440","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2016.08.046","article-title":"Shifting paradigms: What is the true prevalence and clinical course of primary sclerosing cholangitis?","volume":"151","author":"Weersma","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0445","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13516","article-title":"Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD","volume":"43","author":"Fevery","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0450","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"De Vries","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0455","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.3748\/wjg.v22.i22.5267","article-title":"Inflammatory bowel disease: A descriptive study of 716 local Chilean patients","volume":"22","author":"Simian","year":"2016","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0460","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011","volume":"38","author":"Sorensen","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0465","doi-asserted-by":"crossref","first-page":"S-20","DOI":"10.1016\/S0016-5085(18)30548-1","article-title":"Usefulness of systematic liver biopsy during a surgery for inflammatory bowel disease for the diagnosis of primary sclerosing cholangitis","volume":"154","author":"Miard","year":"2018","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0470","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0475","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.dld.2018.06.024","article-title":"Tract systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease","volume":"50","author":"Belle","year":"2018","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0480","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","article-title":"Genetic epidemiology of primary sclerosing cholangitis","volume":"13","author":"Karlsen","year":"2007","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0485","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gastrohep.2010.02.006","article-title":"Colangitis esclerosante primaria: diagn\u00f3stico y tratamiento","volume":"34","author":"Par\u00e9s","year":"2011","journal-title":"Gastroenterol Hepatol (NY)."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0490","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0495","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0500","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/CEG.S105872","article-title":"Primary sclerosing cholangitis: Diagnostic and management challenges","volume":"10","author":"Sirpal","year":"2017","journal-title":"Clin Exp Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0505","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl Med."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0515","first-page":"293","article-title":"Primary sclerosing cholangitis, Part 1: Epidemiology, etiopathogenesis, clinical features, and treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol (NY)."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0520","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: A review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0525","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/gutjnl-2017-314249","article-title":"Cholangiocytes and the environment in primary sclerosing cholangitis: Where is the link?","volume":"66","author":"O\u2019Hara","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0530","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MJT.0b013e3181b7b8c0","article-title":"Antibiotics for the treatment of primary sclerosing cholangitis","volume":"18","author":"Elfaki","year":"2011","journal-title":"Am J Ther."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0535","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/MEG.0000000000001223","article-title":"Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis","volume":"30","author":"De Chambrum","year":"2018","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0540","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.27927","article-title":"Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis","volume":"63","author":"Tabbian","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0545","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0550","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0555","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterized by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0560","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0565","first-page":"1","article-title":"Primay sclerosing cholangitis in children versus adults: Lessons for the clinic","volume":"10","author":"Adike","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0570","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00535-018-1484-9","article-title":"Clinical guidelines for primary sclerosing cholangitis 2017","volume":"53","author":"Isayama","year":"2018","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0575","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3109\/00365521.2014.940376","article-title":"Spyglass single-operator peroral cholangioscopy seems promising in the evaluation of primary sclerosing cholangitis \u2014 related biliary strictures","volume":"49","author":"Siiki","year":"2014","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0580","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4253\/wjge.v6.i4.137","article-title":"Efficacy of SpyGlass\u2122-directed biopsy compared to brush cytology in obtaining adequate tissue for diagnosis in patients with biliary strictures","volume":"6","author":"Rey","year":"2014","journal-title":"World J Gastrointest Endosc."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0585","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cld.2017.06.004","article-title":"Primary sclerosing cholangitis: What the gastroenterologist and hepatologist needs to know","volume":"21","author":"Gossard","year":"2017","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0590","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0595","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","article-title":"Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon","volume":"16","author":"Cleveland","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0600","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3109\/00365521.2014.907824","article-title":"Mortality n inflammatory bowel disease patients under 65 years of age","volume":"49","author":"O\u2019Toole","year":"2014","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0605","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3748\/wjg.v23.i14.2459","article-title":"Pathogenesis and clinical spectrum of primary sclerosing cholangitis","volume":"23","author":"Gidwaney","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0610","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD","volume":"111","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0615","first-page":"427","article-title":"Primary sclerosing cholangitis. Part 2: Cancer risk, prevention and surveillance","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol (NY)."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0620","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord","year":"2016","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0625","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-0037-1602237","article-title":"Colorectal cancer in inflammatory bowel disease","volume":"31","author":"Stidham","year":"2018","journal-title":"Clin Colon Rectal Surg."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0630","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.3748\/wjg.v20.i27.8783","article-title":"Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: A review of the literature","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0635","first-page":"43","article-title":"Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease","volume":"4","author":"Navaneethan","year":"2016","journal-title":"Gastroenterol Rep (Oxf)."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0640","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.crohns.2013.02.002","article-title":"Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"7","author":"Venkatesh","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0645","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.giec.2014.04.002","article-title":"Surgical management of nonpolypoid colorectal lesions and strictures in colonic inflammatory bowel disease","volume":"24","author":"Coviello","year":"2014","journal-title":"Gastrointest Endosc Clin N Am."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0650","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: Primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0655","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.crohns.2013.09.016","article-title":"European evidence based consensus for endoscopy in inflammatory bowel disease","volume":"7","author":"Annese","year":"2013","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0660","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOG.0000000000000444","article-title":"Inflammatory bowel disease therapy: Blockade of cytokines and cytokine signaling pathways","volume":"34","author":"Yamamoto-Furosho","year":"2018","journal-title":"Curr Opin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0665","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0670","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MEG.0000000000000847","article-title":"Lack of efficacy of infliximab in the treatment of primary sclerosing","volume":"29","author":"Cardile","year":"2017","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0675","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCG.0b013e3181662426","article-title":"A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis","volume":"42","author":"Hommes","year":"2008","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0680","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/apt.14829","article-title":"Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease","volume":"48","author":"Tse","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0685","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bone.2010.09.001","article-title":"TNF-alpha stimulates alkaline phosphatase and mineralization through PPARgamma inhibition in human osteoblasts","volume":"48","author":"Lencel","year":"2011","journal-title":"Bone."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0690","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0695","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/apt.14525","article-title":"Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease","volume":"47","author":"Christensen","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0700","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ecco-jcc\/jjx057","article-title":"Safety of anti-TNF treatment in liver transplant recipients \u2014 a systematic review and meta-analysis","volume":"11","author":"Westerouen van Meeteren","year":"2017","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0705","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0710","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/ibd.21594","article-title":"Primary sclerosing cholangitis is associated with endoscopic and histologic inflammation of the distal afferent limb in patients with ileal pouch-anal anastomosis","volume":"17","author":"Shen","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0715","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.crohns.2013.12.007","article-title":"Comes after ileal pouch anal anastomosis in patients with primary sclerosing cholangitis","volume":"8","author":"Pavlides","year":"2014","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0720","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0725","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.3748\/wjg.v23.i18.3214","article-title":"Inflammatory bowel disease in liver transplanted patients","volume":"23","author":"Kanizaj","year":"2017","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0730","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17474124.2017.1343666","article-title":"Interactions between primary sclerosing cholangitis and inflammatory bowel disease: Implications in the adult liver transplant setting","volume":"11","author":"Liu","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0735","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: Risk factors for recurrence and de novo disease","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation: A single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0745","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/MIB.0000000000001105","article-title":"Clinical course of ulcerative colitis after liver transplantation in patients with concomitant primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Fattahi","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0750","first-page":"626","article-title":"A review of inflammatory bowel disease in the setting of liver transplantation","volume":"10","author":"Nannegari","year":"2014","journal-title":"Gastroenterol Hepatol (NY)."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0755","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0760","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41395-018-0049-0","article-title":"The Gastroenterologist's guide to management of the post liver transplant patient","volume":"113","author":"Chacsa","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0765","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"Jorgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0770","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.3748\/wjg.v24.i28.3171","article-title":"Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients","volume":"24","author":"Buchholz","year":"2018","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0775","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0780","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0785","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0037-1608655","article-title":"Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis","volume":"37","author":"Martin","year":"2017","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.gastrohep.2019.02.004_bib0790","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: A Nordic multicentre study","volume":"53","author":"Lindstrom","year":"2018","journal-title":"Scand J Gastroenterol."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051930055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S021057051930055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:43:18Z","timestamp":1759322598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S021057051930055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S021057051930055X"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2019.02.004","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelaci\u00f3n intestino-h\u00edgado","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}